Epivax Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Epivax

Access the complete profile.

Epivax Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	5417 Scientific Research & Development Services
Additional NAICS Codes	541711 Research & Development in Biotechnology
Address	188 Valley St Ste 424 Providence, RI 02909

Note: Revenues for privately held companies are statistical evaluations.


Epivax's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Epivax's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Epivax is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Epivax Annual Revenue and Growth Rate

Epivax	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Epivax's revenues are gauged from an analysis of company filings.

Epivax's Income Statement (based on Industry Averages)

Epivax P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Epivax is developing and marketing. Epivax doesn't have any recent trademark applications, indicating Epivax is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
PANDA Health screening services in the field of immunogenicity; Providing medical information to scientists in the form of reports in the field of immunogenicity	12/15/2020
EPIVAX ONCOLOGY Medical analysis services for the treatment of cancer, namely, processing of cancer and normal protein sets and identifying high-quality patient specific neo-antigens	01/09/2017
EPIMATRIX Research, development, engineering and testing services in the fields of proteins and T cell vaccines; Providing temporary use of non- downloadable software to predict the immunogenicity of protein therapeutics, to deimmunize proteins and to design T cell vaccines	01/09/2017

See all trademarks and details in the Full Report.

Market Share of Epivax's Largest Competitors

A competitive analysis shows these companies are in the same general field as Epivax, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Epivax. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
ALCOR SCIENTIFIC	Smithfield, RI	100
OCEAN STATE RESEARCH INSTITUTE	Providence, RI	82
EPIVAX	Providence, RI	45
SPECTRA SYSTEMS	Providence, RI	27
INNOVATIVE POLICY LAB	Providence, RI	22
ILLUNINOSS MEDICAL	East Providence, RI	13

Other Companies at 188 Valley St, Providence RI

Company	Headquarters	Revenue ($ MM)
UPWARD HEALTH NATIONAL	Providence, RI	100
BIG BROTHERS BIG SISTERS OF RHODE ISLAND	Providence, RI	2
EPIVAX THERAPEUTICS	Providence, RI	0
CHILDREN & YOUTH CABINET	Providence, RI	0

Future Competition: Epivax's Fastest Growing Competitors

These companies are in the same general field as Epivax and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)